Literature DB >> 23158928

CXCR6 deficiency ameliorated myocardial ischemia/reperfusion injury by inhibiting infiltration of monocytes and IFN-γ-dependent autophagy.

Gang Zhao1, Shijun Wang, Zhen Wang, Aijun Sun, Xiangdong Yang, Zhaohui Qiu, Chaoneng Wu, Wenbin Zhang, Hua Li, Youen Zhang, Jingjing Zhao, Yunzeng Zou, Junbo Ge.   

Abstract

BACKGROUND: Emerging evidence shows that the chemokine CXCL16 plays an important role in the pathogenesis of myocardial remodeling and development of heart failure following ischemia/reperfusion (I/R) injury. CXCR6, the receptor for CXCL16, is also critically involved. However, the underlying mechanism remained uncertain, and the aim of this research was to investigate this mechanism in CXCR6 knockout (KO) mice. METHODS AND
RESULTS: CXCR6 KO mice and wild type (WT) mice had no overt phenotype at baseline in the absence of injury, but difference was shown in response to I/R induction. Compared with WT mice, CXCR6 KO mice exhibited a lower infarction size (31.86 ± 1.808% vs. 43.09 ± 1.519%), and better cardiac function (measured by LVEF, LVFS, +dp/dt, LVEDP, and LVSP) following I/R. Moreover, cardiac levels of IFN-γ and IFN-γ-dependent autophagy were found to be significantly attenuated in CXCR6 KO mice. Further data showed that cardiac-enhanced IFN-γ secretion was not induced by cardiomyocytes, but by infiltrated monocytes in the myocardium in response to I/R injury. In vivo injection of IFN-γ and in vitro co-cultured cardiomyocytes with CD11b+ monocytes confirmed IFN-γ activated autophagic response, and induced cardiac dysfunction in a paracrine manner.
CONCLUSIONS: The study suggested that since disruption of the CXCL16/CXCR6 signaling cascade had a cardio-protective effect against I/R injury, the underlying mechanism might be that I/R triggered the infiltration of monocytes into the myocardium, and induced cardiac autophagy through CXCL16/CXCR6-dependent paracrine secretion of IFN-γ. Crown
Copyright © 2012. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Autophagy; CXCL16; CXCR6; IFN-γ; Ischemia/reperfusion injury

Mesh:

Substances:

Year:  2012        PMID: 23158928     DOI: 10.1016/j.ijcard.2012.10.022

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  23 in total

1.  Pharmacological modulation of autophagy to protect cardiomyocytes according to the time windows of ischaemia/reperfusion.

Authors:  Qiulin Xu; Xixian Li; Yongkang Lu; Liang Shen; Jingwen Zhang; Shiping Cao; Xiaobo Huang; Jianping Bin; Yulin Liao
Journal:  Br J Pharmacol       Date:  2015-04-10       Impact factor: 8.739

2.  CXCR6 deficiency attenuates pressure overload-induced monocytes migration and cardiac fibrosis through downregulating TNF-α-dependent MMP9 pathway.

Authors:  Jia-Hong Wang; Feng Su; Shijun Wang; Xian-Cheng Lu; Shao-Heng Zhang; De Chen; Nan-Nan Chen; Jing-Quan Zhong
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

3.  Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes.

Authors:  Christopher R Cogle; Elizabeth Wise; Amy M Meacham; Claudia Zierold; Jay H Traverse; Timothy D Henry; Emerson C Perin; James T Willerson; Stephen G Ellis; Marjorie Carlson; David X M Zhao; Roberto Bolli; John P Cooke; Saif Anwaruddin; Aruni Bhatnagar; Maria da Graca Cabreira-Hansen; Maria B Grant; Dejian Lai; Lem Moyé; Ray F Ebert; Rachel E Olson; Shelly L Sayre; Ivonne H Schulman; Raphael C Bosse; Edward W Scott; Robert D Simari; Carl J Pepine; Doris A Taylor
Journal:  Circ Res       Date:  2014-08-18       Impact factor: 17.367

4.  CXCR6 Mediates Pressure Overload-Induced Aortic Stiffness by Increasing Macrophage Recruitment and Reducing Exosome-miRNA29b.

Authors:  Shijun Wang; Jian Wu; Xuan Li; Rubin Tan; Liming Chen; Lifan Yang; Fangjie Dai; Leilei Ma; Lei Xu; Zhen Wang; Gang Zhao; Junbo Ge; Yunzeng Zou
Journal:  J Cardiovasc Transl Res       Date:  2022-08-26       Impact factor: 3.216

5.  Hydrogen sulfide attenuates the recruitment of CD11b⁺Gr-1⁺ myeloid cells and regulates Bax/Bcl-2 signaling in myocardial ischemia injury.

Authors:  Youen Zhang; Hua Li; Gang Zhao; Aijun Sun; Nobel C Zong; Zhaofeng Li; Hongming Zhu; Yunzeng Zou; Xiangdong Yang; Junbo Ge
Journal:  Sci Rep       Date:  2014-04-24       Impact factor: 4.379

6.  The predictive Value of Total Neutrophil Count and Neutrophil/Lymphocyte Ratio in Predicting In-hospital Mortality and Complications after STEMI.

Authors:  Samad Ghaffari; Mehdi Nadiri; Leili Pourafkari; Nariman Sepehrvand; Aliakbar Movasagpoor; Neda Rahmatvand; Mohammadamin Rezazadeh Saatloo; Mona Ahmadi; Nader D Nader
Journal:  J Cardiovasc Thorac Res       Date:  2014-03-21

Review 7.  Myocardial infarction: a critical role of macrophages in cardiac remodeling.

Authors:  Tobias Weinberger; Christian Schulz
Journal:  Front Physiol       Date:  2015-04-07       Impact factor: 4.566

8.  bFGF regulates autophagy and ubiquitinated protein accumulation induced by myocardial ischemia/reperfusion via the activation of the PI3K/Akt/mTOR pathway.

Authors:  Zhou-Guang Wang; Yue Wang; Yan Huang; Qin Lu; Lei Zheng; Dong Hu; Wen-Ke Feng; Yan-Long Liu; Kang-Ting Ji; Hong-Yu Zhang; Xiao-Bing Fu; Xiao-Kun Li; Mao-Ping Chu; Jian Xiao
Journal:  Sci Rep       Date:  2015-03-19       Impact factor: 4.379

9.  Aliskiren-attenuated myocardium apoptosis via regulation of autophagy and connexin-43 in aged spontaneously hypertensive rats.

Authors:  Wenbin Zhang; Gang Zhao; Xiaona Hu; Min Wang; Hua Li; Yong Ye; Qijun Du; Jin Yao; Zhijun Bao; Wei Hong; Guosheng Fu; Junbo Ge; Zhaohui Qiu
Journal:  J Cell Mol Med       Date:  2014-04-06       Impact factor: 5.310

10.  The perioperative time course and clinical significance of the chemokine CXCL16 in patients undergoing cardiac surgery.

Authors:  Daniela Dreymueller; Andreas Goetzenich; Christoph Emontzpohl; Josefin Soppert; Andreas Ludwig; Christian Stoppe
Journal:  J Cell Mol Med       Date:  2015-10-23       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.